Holen Sie sich die Stockscreener-App
0.7551
0.87%
-0.00659
Schlusskurs vom Vortag:
$0.7617
Offen:
$0.7402
24-Stunden-Volumen:
82,731
Relative Volume:
0.08
Marktkapitalisierung:
$5.30M
Einnahmen:
$5.75M
Nettoeinkommen (Verlust:
$-38.96M
KGV:
-0.0606
EPS:
-12.47
Netto-Cashflow:
$-32.63M
1W Leistung:
-9.35%
1M Leistung:
-50.97%
6M Leistung:
-79.86%
1J Leistung:
-88.86%
1-Tages-Spanne:
$0.7402
$0.7998
1-Wochen-Bereich:
$0.74
$0.818
52-Wochen-Spanne:
$0.74
$20.60
Kala Bio Inc Stock (KALA) Company Profile
Firmenname
Kala Bio Inc
Sektor
Branche
Telefon
781-996-5252
Adresse
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Vergleichen Sie KALA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
0.7551 | 5.35M | 5.75M | -38.96M | -32.63M | -12.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.60 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.82 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.92 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.38 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-30 | Herabstufung | Mizuho | Outperform → Neutral |
| 2025-09-29 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-09-29 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2025-09-08 | Eingeleitet | Mizuho | Outperform |
| 2025-07-11 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-03-30 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-08-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-09-14 | Herabstufung | Jefferies | Buy → Hold |
| 2020-07-23 | Eingeleitet | Northland Capital | Outperform |
| 2020-06-01 | Fortgesetzt | Oppenheimer | Outperform |
| 2020-05-27 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-09 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-12-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-03-14 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Kala Bio Inc Aktie (KALA) Neueste Nachrichten
KALA BIO Inc. stock trend outlook and recovery pathJuly 2025 Fed Impact & Daily Growth Stock Tips - newser.com
Applying Elliott Wave Theory to KALA BIO Inc.Quarterly Earnings Summary & Short-Term High Return Strategies - newser.com
Is KALA BIO Inc. stock vulnerable to regulatory risksJuly 2025 Reactions & Growth Focused Stock Reports - newser.com
Risk vs reward if holding onto KALA BIO Inc.Weekly Profit Recap & Capital Efficiency Focused Ideas - newser.com
Is KALA BIO Inc. stock supported by innovation pipelineJuly 2025 Intraday Action & Precise Entry and Exit Recommendations - newser.com
Best data tools to analyze KALA BIO Inc. stock2025 Retail Activity & Real-Time Price Movement Reports - newser.com
How supply chain issues affect KALA BIO Inc. stockJuly 2025 Retail & AI Based Buy/Sell Signal Reports - newser.com
Is KALA BIO Inc. stock trading at a premium valuationJuly 2025 Movers & Safe Capital Investment Plans - newser.com
What Indicators Suggest Overbought Oversold Levels in Riddhi Steel and Tube LimitedMACD Histogram Signals & Amplify Gains With Picks - earlytimes.in
Will KALA BIO Inc. stock outperform international peersEarnings Beat & Free Community Consensus Stock Picks - newser.com
Will KALA BIO Inc. stock sustain high P E ratios2025 Top Decliners & Short-Term Swing Trade Alerts - newser.com
Measuring KALA BIO Inc.’s beta against major indicesGold Moves & Weekly Top Gainers Alerts - newser.com
Real time scanner hits for KALA BIO Inc. explained2025 Breakouts & Breakdowns & Reliable Volume Spike Trade Alerts - newser.com
Applying big data sentiment scoring on KALA BIO Inc.Weekly Profit Analysis & Stepwise Entry and Exit Trade Signals - newser.com
Using fundamentals and technicals on KALA BIO Inc.Dip Buying & Intraday High Probability Setup Alerts - newser.com
Will KALA BIO Inc. outperform the marketWeekly Market Report & Expert Curated Trade Setup Alerts - newser.com
Published on: 2025-11-03 03:43:51 - newser.com
What to do if you’re stuck in KALA BIO Inc.Earnings Summary Report & Community Driven Trade Alerts - newser.com
Detecting support and resistance levels for KALA BIO Inc.Weekly Market Summary & Fast Entry and Exit Trade Plans - newser.com
Will KALA BIO Inc. stock recover after recent dropJuly 2025 Outlook & Free Technical Pattern Based Buy Signals - newser.com
How hedge fund analytics apply to KALA BIO Inc. stockEarnings Overview Summary & Low Volatility Stock Suggestions - newser.com
Is KALA BIO Inc. stock a contrarian buyJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - newser.com
Real time alert setup for KALA BIO Inc. performanceJuly 2025 Outlook & Low Risk High Win Rate Picks - newser.com
When is the best time to exit KALA BIO Inc.2025 Performance Recap & Free Technical Confirmation Trade Alerts - newser.com
What drives KALA BIO Inc stock priceUtilities Sector Analysis & Rapid Portfolio Expansion - earlytimes.in
Is KALA BIO Inc a good long term investmentCash Flow Trends & Identify Breakout Stocks - earlytimes.in
Chart based exit strategy for KALA BIO Inc.July 2025 Snapshot & Safe Capital Investment Plans - newser.com
Will KALA BIO Inc. stock deliver shareholder value2025 Technical Patterns & Reliable Price Action Trade Plans - newser.com
A Heavy Trading Day Sends Biotech And Finance Stocks Reeling - Finimize
Will KALA BIO Inc. stock outperform value stocks2025 Geopolitical Influence & Verified Momentum Stock Watchlist - newser.com
Finanzdaten der Kala Bio Inc-Aktie (KALA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kala Bio Inc-Aktie (KALA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Reumuth Mary | CHIEF FINANCIAL OFFICER |
Oct 22 '25 |
Sale |
0.83 |
32,230 |
26,751 |
29,873 |
| Reumuth Mary | CHIEF FINANCIAL OFFICER |
Oct 23 '25 |
Sale |
0.82 |
967 |
793 |
28,906 |
| Bazemore Todd | Director |
Oct 22 '25 |
Sale |
0.83 |
47,768 |
39,647 |
35,932 |
| Brazzell Romulus K | SEE REMARKS |
Oct 22 '25 |
Sale |
0.83 |
46,748 |
38,801 |
35,952 |
| Kharabi Darius | CHIEF BUSINESS OFFICER |
Oct 22 '25 |
Sale |
0.83 |
20,806 |
17,269 |
41,760 |
1.24%
0.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):